COVID-19 Impact on Global Pharmaceutical Contract Development and Manufacturing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Pharmaceutical Manufacturing Services
  • 1.4.3 Biologics Manufacturing Services
  • 1.4.4 Drug Development Services
• 1.5 Market by Application
  • 1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2020 VS 2026
  • 1.5.2 Big Pharma
  • 1.5.3 Small Pharma
  • 1.5.4 Generic Pharma
  • 1.5.5 CRO
• 1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Contract Development and Manufacturing Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Pharmaceutical Contract Development and Manufacturing Industry
    • 1.6.1.1 Pharmaceutical Contract Development and Manufacturing Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Pharmaceutical Contract Development and Manufacturing Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Pharmaceutical Contract Development and Manufacturing Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Pharmaceutical Contract Development and Manufacturing Market Perspective (2015-2026)
• 2.2 Pharmaceutical Contract Development and Manufacturing Growth Trends by Regions
  • 2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmaceutical Contract Development and Manufacturing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmaceutical Contract Development and Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Market Size
  • 3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
  • 3.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2019
• 3.3 Pharmaceutical Contract Development and Manufacturing Key Players Head office and Area Served
• 3.4 Key Players Pharmaceutical Contract Development and Manufacturing Product Solution and Service
• 3.5 Date of Enter into Pharmaceutical Contract Development and Manufacturing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)
• 5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 6.2 Pharmaceutical Contract Development and Manufacturing Key Players in North America (2019-2020)
• 6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 7.2 Pharmaceutical Contract Development and Manufacturing Key Players in Europe (2019-2020)
• 7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 8.2 Pharmaceutical Contract Development and Manufacturing Key Players in China (2019-2020)
• 8.3 China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 8.4 China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 9.2 Pharmaceutical Contract Development and Manufacturing Key Players in Japan (2019-2020)
• 9.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 9.4 Japan Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 10.2 Pharmaceutical Contract Development and Manufacturing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 11.2 Pharmaceutical Contract Development and Manufacturing Key Players in India (2019-2020)
• 11.3 India Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 11.4 India Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

12 Central and South America

• 12.1 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size (2015-2020)
• 12.2 Pharmaceutical Contract Development and Manufacturing Key Players in Central and South America (2019-2020)
• 12.3 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2015-2020)
• 12.4 Central and South America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Thermo Fisher Scientific Inc. Company Details
  • 13.1.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  • 13.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific Inc. Recent Development
• 13.2 Catalent, Inc.
  • 13.2.1 Catalent, Inc. Company Details
  • 13.2.2 Catalent, Inc. Business Overview and Its Total Revenue
  • 13.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.2.5 Catalent, Inc. Recent Development
• 13.3 Lonza Group Ltd
  • 13.3.1 Lonza Group Ltd Company Details
  • 13.3.2 Lonza Group Ltd Business Overview and Its Total Revenue
  • 13.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.3.5 Lonza Group Ltd Recent Development
• 13.4 Recipharm AB
  • 13.4.1 Recipharm AB Company Details
  • 13.4.2 Recipharm AB Business Overview and Its Total Revenue
  • 13.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.4.5 Recipharm AB Recent Development
• 13.5 Vetter Pharma International GMBH
  • 13.5.1 Vetter Pharma International GMBH Company Details
  • 13.5.2 Vetter Pharma International GMBH Business Overview and Its Total Revenue
  • 13.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.5.5 Vetter Pharma International GMBH Recent Development
• 13.6 FAMAR Health Care Services
  • 13.6.1 FAMAR Health Care Services Company Details
  • 13.6.2 FAMAR Health Care Services Business Overview and Its Total Revenue
  • 13.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.6.5 FAMAR Health Care Services Recent Development
• 13.7 AbbVie Inc.
  • 13.7.1 AbbVie Inc. Company Details
  • 13.7.2 AbbVie Inc. Business Overview and Its Total Revenue
  • 13.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.7.5 AbbVie Inc. Recent Development
• 13.8 Aenova Group
  • 13.8.1 Aenova Group Company Details
  • 13.8.2 Aenova Group Business Overview and Its Total Revenue
  • 13.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.8.5 Aenova Group Recent Development
• 13.9 Consort Medical plc
  • 13.9.1 Consort Medical plc Company Details
  • 13.9.2 Consort Medical plc Business Overview and Its Total Revenue
  • 13.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.9.5 Consort Medical plc Recent Development
• 13.10 Almac Group
  • 13.10.1 Almac Group Company Details
  • 13.10.2 Almac Group Business Overview and Its Total Revenue
  • 13.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
  • 13.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 13.10.5 Almac Group Recent Development
• 13.11 Siegfried Holding AG
  • 10.11.1 Siegfried Holding AG Company Details
  • 10.11.2 Siegfried Holding AG Business Overview and Its Total Revenue
  • 10.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
  • 10.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 10.11.5 Siegfried Holding AG Recent Development
• 13.12 Boehringer Ingelheim International GmbH
  • 10.12.1 Boehringer Ingelheim International GmbH Company Details
  • 10.12.2 Boehringer Ingelheim International GmbH Business Overview and Its Total Revenue
  • 10.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction
  • 10.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 10.12.5 Boehringer Ingelheim International GmbH Recent Development
• 13.13 Evonik Industries AG
  • 10.13.1 Evonik Industries AG Company Details
  • 10.13.2 Evonik Industries AG Business Overview and Its Total Revenue
  • 10.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
  • 10.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2015-2020)
  • 10.13.5 Evonik Industries AG Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer